Earnings Call · Q1 FY2024·2024-05-01

Q1 24EPS -2.70%·Rev n/aQ4 23EPS -7.89%·Rev n/aQ3 23EPS -1.45%·Rev n/aQ2 23EPS -57.89%·Rev n/a⚠ consensus missing

Schrodinger, Inc. SDGR

Jaren Madden — Head of Investor Relations

Ramy Farid — Chief Executive Officer

Geoffrey Porges — Chief Financial Officer

Karen Akinsanya — President, R&D, Therapeutics

−8.2%1d on move date−9.1% vs SPY3d−4.8%5d−8.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SDGR calls or request research access.

More SDGR calls Browse calls Request research access